“…Reactive astrocytes produce a number of neurotrophic factors upon spinal cord and brain injuries. These include brain-derived neurotrophic factor (BDNF) known to promote neuronal survival and axon growth ( Dougherty et al, 2000 ; Ikeda et al, 2001 ); ciliary neurotrophic factor (CNTF) ( Lee et al, 1998 ; Tripathi and McTigue, 2008 ; Chen et al, 2022 ) shown to robustly stimulate axon regeneration and sprouting of CNS axons ( Muller et al, 2007 ; Jin et al, 2015 ); nerve growth factor (NGF) ( Goss et al, 1998 ; Krenz and Weaver, 2000 ) that enhances axon regrowth ( Tuszynski et al, 2002 ; Hannila and Kawaja, 2005 ; Mesentier-Louro et al, 2019 ) using reactive astrocytes as a substrate ( Kawaja and Gage, 1991 ); fibroblast growth factor 2 (FGF2) ( do Carmo Cunha et al, 2007 ) shown to promote CNS axon branching ( Szebenyi et al, 2001 ) and sensory axon regeneration ( Lee et al, 2017 ); hepatocyte growth factor (HGF) ( Shimamura et al, 2007 ) capable of increasing CNS axon regrowth ( Kitamura et al, 2007 ; Yamane et al, 2018 ); and insulin-like growth factor 1 (IGF1) ( Yao et al, 1995 ) with potent regeneration-stimulatory activity on corticospinal axons ( Hollis et al, 2009 ; Liu et al, 2017 ). Human spinal cord astrocytes, when stimulated with IL1β to undergo astrogliosis in vitro , also express the growth factors such as FGF2, BDNF, and NGF, adapting an overall axon growth-permissive phenotype ( Teh et al, 2017 ).…”